CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.

Go behind the scenes with Jim Cramer and Jeff Marks of the CNBC Investing Club as they talk candidly about the market's ...

Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to spotlight Chemical stocks in his "Best ...

Whether a stock needs to stay or go requires holistic evaluation, not just short-term comparisons to the S&P 500.

CNBC’s Jim Cramer talks about Target's stock performance, its recent earnings report and what he thinks of the retailer's ...

Broadcom shares gained nearly 2% ahead of earnings after the close. The Club wants to see more than $8 billion in AI revenue for the reported quarter and more than $9 billion projected for the April ...

CNBC's Jim Cramer discusses what he thinks of Forgent Power Solution, which is the largest IPO of 2026 thus far.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...

These stocks are asset-heavy, which may make them more insulated from risks that emerge in an AI economy, the firm says.

Check out the companies making headlines before the bell. Moderna — The biotechnology firm rose nearly 11% after it said it agreed to pay up to $2.25 billion to settle a lawsuit with Biopharma Corp.

Black gold, Texas tea, dino juice, or whatever you want to call it, oil is the lifeblood of the global economy. Whether it's ...